Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


Researchers at the University of Florida Health have found a way to inhibit or reverse multiple sclerosis (MS) using a novel gene therapy technique that stops the condition’s immune response in...

Scientists at Yale University have uncovered two closely related cytokines – molecules involved in cell communication and movement – that may explain why some people develop progressive multiple...

Two new studies from the U.S and Germany have added to growing evidence that gut bacteria may play a role in the brain inflammation caused by Multiple Sclerosis.

The first study, titled...

Bexarotene, a drug that could help the brain regrow myelin in people with MS, has started its phase II clinical trial.

Researchers at Cambridge Centre for Myelin Repair and Edinburgh Centre...

NHS England has launched a series of practical guides to help disabled patients access GP online services.

Aimed at supporting people with sight loss, hearing loss, autism or learning...

The Disability Benefits Consortium (DBC) has today released a report revealing the true failings of the UK’s Personal Independence Payment (PIP) system.

In order to examine how well PIP is...

Examining vitamin D levels in the blood may help predict whether a person is at risk of developing multiple sclerosis (MS), according to a large new study published in an online issue of Neurology...

Last year, only 56% of people with MS received disease modifying treatments (DMT) across the UK, this is according to a recent national survey conducted by the MS Society. This is 16% higher than...

New Zealand researchers have created a smartphone app that could help thousands of people with multiple sclerosis (MS).

The app, MS Energise, supports the management of MS fatigue using an...

A phase III Paradigms study in paediatric multiple sclerosis (MS) has met its primary end point, showing a significant reduction in the occurrence of relapses with Gileyna (also known as...

Pages

Live Chat Software by Click4Assistance UK